SOX2 and gastric cancer: EVs-L-PGDS inhibited gastric cancer growth, induced cell apoptosis, reduced the expression of stem cell markers including Oct4, Nanog, and Sox2, and inhibited STAT3 phosphorylation in SGC-7901 gastric cancer cells [177].